The implication of LIGHT in driving inflammatory and autoimmune diseases such as arthritis, inflammatory bowel disease (IBD), lupus and multiple sclerosis has drawn the attention of many scientists, and blockade of LIGHT-mediated inflammation is now being pursued for the treatment of autoimmune diseases clinically [12]. Here, TNFSF14 is linked to inflammatory bowel disease.